BioPharmSignal logoBioPharmSignal

Biotech News

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

SIGA Technologies Inc (SIGA)SIGA Technologies IncEarnings

SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Monday, November 9, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.

Related news

SIGASIGA Technologies Inc2026-07-30 11:30 EST

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

SIGASIGA Technologies Inc2026-08-06 20:01 EST

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026

AVIRAtea2026-11-02 21:05 EST

Atea Pharmaceuticals to Host Third Quarter 2026 Financial Results and Business Update Conference Call on November 9, 2026

IMNNImunon2026-11-02 13:30 EST

IMUNON to Hold Third Quarter 2026 Financial Results and Business Update Conference Call on Thursday, November 12, 2026

AVIRAtea2026-08-05 11:00 EST

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

VIRIVirios Therapeutics2026-11-05 13:30 EST

Dogwood Therapeutics Announces Third Quarter 2026 Financial Results

SCYXSCYNEXIS2026-11-05 13:20 EST

SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update

IMNNImunon2026-08-04 12:00 EST

IMUNON to Hold Second Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, August 11, 2026

SPROSpero Therapeutics2026-08-04 21:01 EST

Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

ENTAEnanta Pharmaceuticals2026-08-10 20:01 EST

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026

View all latest news

SIGA Technologies Inc

SIGA Technologies is a specialty pharmaceutical company best known for its antiviral countermeasure portfolio, especially against orthopox and smallpox-related threats. Its story is tied to government procurement and biodefense demand.

Recent company news

SIGASIGA Technologies Inc2026-10-29 11:30 EST

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

SIGASIGA Technologies Inc2026-08-06 20:01 EST

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026

SIGASIGA Technologies Inc2026-07-30 11:30 EST

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

SIGASIGA Technologies Inc2026-05-07 20:01 EST

SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update

SIGASIGA Technologies Inc2026-04-30 11:30 EST

SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results

Stock data

Close
2.97 USD
Market cap
309.85M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States